课题基金 / 基金详情

Comparative effectiveness and safety profiles of new antiretroviral therapies for the treatment of drug naïve HIV infection: A novel use of network meta-analysis

Comparative effectiveness and safety profiles of new antiretroviral therapies for the treatment of drug naïve HIV infection: A novel use of network meta-analysis
治疗初治 HIV 感染的新型抗逆转录病毒疗法的有效性和安全性比较：网络荟萃分析的新用途
批准号：
296769
负责人：
Kanters Steve
金额：
$7.65万
依托单位：
University of British Columbia
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2013
资助国家：
加拿大
项目状态：
已结题
起止时间：
2013-10-01 至 2016-10-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=296769&lang=en
关键词：
Bayesian Inference Decision Support Tools Drug Safety And Effectiveness Evidence Synthesis First-Line Therapy Hiv/Aids Network Meta-Analyses Patient Decision Making

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Combination antiretroviral therapy (ART) has increased life expectancy for people living with HIV. Current guidelines recommend a combination of two backbone agents and a potent third agent of which a variety of choices exist. However, their comparative e
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金